Physician, scientist, and professor Richard J. Cohen has made influential contributions to the Harvard-MIT Program in Health Sciences and Technology since it began 50 years ago. He will transition to emeritus status in March.
IRVINE, Calif., Jan. 03, 2022 Clinical Laserthermia Systems AB , developer of high precision, image-guided focal laser ablation systems, today announced it has promoted Mr. Michael Magnani to. | January 3, 2022
Clinical Laserthermia Systems AB Promotes Michael Magnani to President of its U.S. Subsidiary, CLS Americas Inc - read this article along with other careers information, tips and advice on BioSpace
Avidity Biosciences Announces Changes to its Board of Directors
Tamar Thompson and Jean Kim appointed to Board of Directors replacing Todd Brady and Michael Martin
News provided by
Share this article
Share this article
LA JOLLA, Calif., Jan. 11, 2021 /PRNewswire/ Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs
™), today announced the appointment of experienced health policy strategist, Tamar Thompson and recognized healthcare investment partner, Jean Kim, to its Board of Directors, who are replacing Todd Brady and Michael Martin. Avidity also announced that Troy Wilson has transitioned from Executive Chairman to Chairman.